The drugs of abuse testing comprises of exposure of one or more illegal or prescribed substances in blood, sweat, saliva, urine or hair. The procedure is carried out with the help of different techniques such as rapid testing, chromatography and immunoassays analyzers. The immunoassays analyzers is the equipment, which helps in biochemical tests that aid detect or measure particular proteins or drug substances.
According to the report published by Future Market Insights, the global market for drugs of abuse testing is anticipated to reach market valuation of more than US$ 2.2 Mn by the end of 2027, witnessing 6.1% CAGR throughout the forecast period.
- Sedative segment, by drug type is the fastest expanding segment in the market and Hallucinogens are anticipated to procure the largest market share over the forecast period.
- Immunoassay segment, by technical type is anticipated to retain its dominance in the market with largest market size of more than US$ 870 Mn projected by 2027-end. Further, the rapid testing segment is anticipated to expand at fastest rate. The forensic laboratories, on the basis of end-use are anticipated to procure largest market share by 2027-end, whereas diagnostic laboratories are estimated to showcase highest CAGR of 6.8% throughout the forecast period.
What are the factors influencing growth of the market?
Increase in the tests rates and technological developments in the drugs of abuse testing have resulted into revenue growth of the market. Several companies are also concentrating on new launch as well as minimizing the cost of the drugs of abuse testing in a way to achieve maximum share of the market.
Increase in the number of clinical labs as well as increasing abuse of clinical drugs are the key factors influencing the expansion of global drugs of abuse testing market. Governments across the globe have further increased expenditure on law enforcement agencies focused on drug interdiction via mandatory screening of potential illicit drug abusers. This is likely to boost demand for drugs of abuse tasting.
However, in several economies such as Latin America, Asia and Africa have lower awareness of drugs of abuse tests and have minimum social backing to minimize the consumption of illicit drugs. Government initiatives are also less in these regions. This is likely to limit the growth of drugs of abuse testing market.
Which region will dominate the global market for drugs of abuse testing?
According to the report, the drugs of abuse testing market in Asia Pacific region is likely to retain its dominance, in terms of CAGR. The market in Asia Pacific region is likely to exhibit CAGR of 7.0% over the forecast period. However, North America is likely to procure largest market share of estimated valuation of US$ 620 Mn by 2027-end.
What are the leading players in the global drugs of abuse testing market?
The comprehensive research report comprises of prominent players operating in the market, which include Express Diagnostics International Inc., Quest Diagnostics, Siemens Healthineers (Siemens AG), Drägerwerk AG & Co. KGaA, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Alere, Inc. (Sub. Abbott Laboratories), Laboratory Corporation of America Holdings, and F.Hoffmann La-Roche Ltd.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1649